This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Global Neurostimulation Industry

Devices II-35

9. RECENT INDUSTRY ACTIVITY II-37Cyberonics Collaborates with Imricor Medical for DevelopingMRI Compatible Leads II-37Boston Scientific Takes Over Intelect Medical II-37GE Healthcare Inks Distribution and Marketing Agreement withKC BioMedix II-37Cyberonics and ImThera to Develop Neurostimulation Technologyfor OSA II-38NDI Medical Establishes New Business Unit for Advancement ofIPG Technology II-38Sonova Holding Acquires Advanced Bionics II-38Medtronic Initiates Clinical Trial for RestoreSensor II-38NeuroMetrix Purchases Select Assets of CyberkineticsNeurotechnology Systems II-39St. Jude Medical Purchases Non-Cash Assets and IntellectualProperty of Northstar Neuroscience II-39Victhom Human Bionics Signs Agreement with Otto Bock HealthCare II-39Neuros Medical Collaborates with Battelle II-40JumpStart & CTV Invest in Neuros Medical II-40InterWest Invests in Autonomic Technologies II-40MicroTransponder Finalizes Series A Funding Round forWireless Neurostimulator Development II-41

10. PRODUCT INNOVATIONS/INTRODUCTIONS II-42

Bioness Launches L300 Plus Foot Drop System in the US For

Patients with Gait Disorders II-42

St.Jude Medical Launches Penta Surgical Leads in Japan II-42

Neurotech® Introduces Kneehab® XP Quadriceps Therapy System II-42

St.Jude Medical Launches Epiducer Lead Delivery System in

Australia II-43

Neurowave Medical Technologies™ Unveils Reletex™

Neuromodulation Device II-43

ST Jude Medical Rolls out Genesis Neurostimulation System in

Japan II-43

Medtronic Unveils Brain Stimulation Products II-44

Alphalife Launches Alpha Brainwave Neurostimulator II-44

ImThera Medical Introduces aura6000™ Neurostimulation System II-44

Mobilis Healthcare Introduces InterX II-44

IMEC Develops and Models New Design for Brain Stimulation

Implants II-45

11. FOCUS ON SELECT PLAYERS II-46Bioness Inc. ( USA) II-46Boston Scientific Corp. ( USA) II-46Cyberonics, Inc. ( USA) II-46Medtronic, Inc. ( USA) II-47St. Jude Medical, Inc. ( USA) II-47Synapse Biomedical, Inc. ( USA) II-48SPR Therapeutics, LLC (US) II-48

12. GLOBAL MARKET PERSPECTIVE II-49

Table 4: World Recent Past, Current & Future Analysis for

Neurostimulation by Geographic Region - US and Rest of World

Markets Independently Analyzed with Annual Sales Figures in

4 of 11

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,959.44 +154.64 0.87%
S&P 500 2,078.54 +7.89 0.38%
NASDAQ 4,781.4240 +16.0440 0.34%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs